相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New graft manipulation strategies improve the outcome of mismatched stem cell transplantation in children with primary immunodeficiencies
Reem Elfeky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
Christopher C. Dvorak et al.
FRONTIERS IN PEDIATRICS (2019)
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal
Ang Li et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome
Xiao-hui Zhang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation
Merve Postalcioglu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
T-cell receptor αβ+ and CD19+ cell-depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency
Ravi M. Shah et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Umbilical cord blood transplantation without in vivo T-cell depletion for children with MHC class II deficiency
Reem Elfeky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Complement in Pathophysiology and Treatment of Transplant -Associated Thrombotic Microangiopathies
Sonata Jodele
SEMINARS IN HEMATOLOGY (2018)
Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD
Sarah A. Wall et al.
BLOOD ADVANCES (2018)
Transplant-associated thrombotic microangiopathy: an unresolved complication of unrelated allogeneic transplant for hematologic diseases
Ioanna Sakellari et al.
HEMATOLOGICAL ONCOLOGY (2017)
The effect of high-dose steroid treatment used for the treatment of acute demyelinating diseases on endothelial and cardiac functions
Mehmet Vedat Caldir et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2017)
In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy
Seth J. Rotz et al.
BLOOD ADVANCES (2017)
Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD
Nicholas J. Gloude et al.
BLOOD (2017)
Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation
L. Yeates et al.
BONE MARROW TRANSPLANTATION (2017)
The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy
Sonata Jodele et al.
BLOOD (2016)
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
Sonata Jodele et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Vascular Alterations in a Murine Model of Acute Graft-Versus-Host Disease Are Associated With Decreased Serum Levels of Adiponectin and an Increased Activity and Vascular Expression of Indoleamine 2,3-Dioxygenase
Peter M. Schmid et al.
CELL TRANSPLANTATION (2016)
New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Sonata Jodele et al.
TRANSFUSION AND APHERESIS SCIENCE (2016)
Hematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatment
Joseph Rosenthal
JOURNAL OF BLOOD MEDICINE (2016)
A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
Sonata Jodele et al.
BLOOD REVIEWS (2015)
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy
K. Balassa et al.
BONE MARROW TRANSPLANTATION (2015)
Low-Dose Serotherapy Improves Early Immune Reconstitution after Cord Blood Transplantation for Primary Immunodeficiencies
Jonathan R. Lane et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Endothelial Dysfunction and Altered Mechanical and Structural Properties of Resistance Arteries in a Murine Model of Graft-versus-Host Disease
Peter M. Schmid et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Eculizumab Therapy in Children with Severe Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Sonata Jodele et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
Sonata Jodele et al.
BLOOD (2014)
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
J. Labrador et al.
BONE MARROW TRANSPLANTATION (2014)
Chronic Hypoxia Promotes Pulmonary Artery Endothelial Cell Proliferation through H2O2-Induced 5-Lipoxygenase
Kristi M. Porter et al.
PLOS ONE (2014)
Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease Prophylaxis
Sepideh Shayani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Endothelial Vulnerability and Endothelial Damage Are Associated with Risk of Graft-versus-Host Disease and Response to Steroid Treatment
Sascha Dietrich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Distinct Deleterious Effects of Cyclosporine and Tacrolimus and Combined Tacrolimus-Sirolimus on Endothelial Cells: Protective Effect of Defibrotide
Alba Carmona et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy
Sonata Jodele et al.
BLOOD (2013)
Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?
Sonata Jodele et al.
TRANSFUSION (2013)
Renal Arteriolar C4d Deposition: A Novel Characteristic of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy
Benjamin L. Laskin et al.
TRANSPLANTATION (2013)
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
Selim Corbacioglu et al.
LANCET (2012)
Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system
Thomas Luft et al.
BLOOD (2011)
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy
Benjamin L. Laskin et al.
BLOOD (2011)
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Olle Ringden et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning
E. Willems et al.
BONE MARROW TRANSPLANTATION (2010)
Validation of Recently Proposed Consensus Criteria for Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem-Cell Transplantation
Byung-Sik Cho et al.
TRANSPLANTATION (2010)
Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy
Y. Inamoto et al.
BONE MARROW TRANSPLANTATION (2009)
Renal Thrombotic Microangiopathy after Hematopoietic Cell Transplant: Role of GVHD in Pathogenesis
Siribha Changsirikulchai et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Thrombotic Microangiopathy in Haematopoietic Stem Cell Transplantation Diagnosis and Treatment
Cecilia M. Choi et al.
DRUGS (2009)
Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
E. D. Batts et al.
BONE MARROW TRANSPLANTATION (2007)
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: Risk factors and response to treatment
Betul Oran et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
Cornelio Uderzo et al.
TRANSPLANTATION (2006)
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation
Hirohisa Nakamae et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Blood and marrow transplant clinical trials network toxicity committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation
VT Ho et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
C Cutler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma
JN George et al.
TRANSFUSION (2004)
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced
A Shimoni et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2004)
Infections and endothelial cells
TT Keller et al.
CARDIOVASCULAR RESEARCH (2003)
Posttransplantation thrombotic thrombocytopenic purpura: A single-center experience and a contemporary review
MA Elliott et al.
MAYO CLINIC PROCEEDINGS (2003)
Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide
G Eissner et al.
BLOOD (2002)
Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes
V Roy et al.
BONE MARROW TRANSPLANTATION (2001)
分享论文
